Business Description
Allergy Therapeutics PLC
ISIN : GB00B02LCQ05
Compare
Compare
Traded in other countries / regions
HHU.GermanyAGY.UKAGYTF.USA IPO Date
2020-08-03Description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.95 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -1.35 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -0.67 | |||||
| Beneish M-Score | -1.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.2 | |||||
| 3-Year Book Growth Rate | 0.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 10.16 | |||||
| 14-Day RSI | 16.92 | |||||
| 6-1 Month Momentum % | -65.33 | |||||
| 12-1 Month Momentum % | -79.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.38 | |||||
| Quick Ratio | 1.74 | |||||
| Cash Ratio | 1.15 | |||||
| Days Inventory | 171.81 | |||||
| Days Sales Outstanding | 27.47 | |||||
| Days Payable | 175.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.03 | |||||
| Operating Margin % | -16.83 | |||||
| Net Margin % | -18.93 | |||||
| ROE % | -29.12 | |||||
| ROA % | -16.29 | |||||
| ROIC % | -34.82 | |||||
| ROC (Joel Greenblatt) % | -54.77 | |||||
| ROCE % | -17.89 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.59 | |||||
| PB Ratio | 1.04 | |||||
| Price-to-Tangible-Book | 1.19 | |||||
| EV-to-EBIT | -2.71 | |||||
| EV-to-Forward-EBIT | -2 | |||||
| EV-to-EBITDA | -4.15 | |||||
| EV-to-Forward-EBITDA | -3.18 | |||||
| EV-to-Revenue | 0.45 | |||||
| EV-to-Forward-Revenue | 0.37 | |||||
| EV-to-FCF | -1.84 | |||||
| Price-to-Projected-FCF | 4.75 | |||||
| Price-to-Median-PS-Value | 0.28 | |||||
| Price-to-Net-Current-Asset-Value | 4.75 | |||||
| Earnings Yield (Greenblatt) % | -36.9 | |||||
| Forward Rate of Return (Yacktman) % | -4.66 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Allergy Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 85.352 | ||
| EPS (TTM) (€) | -0.026 | ||
| Beta | 0 | ||
| Volatility % | 65.35 | ||
| 14-Day RSI | 16.92 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.0475 | ||
| 12-1 Month Momentum % | -79.7 | ||
| 52-Week Range (€) | 0.047 - 0.234 | ||
| Shares Outstanding (Mil) | 679.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Allergy Therapeutics PLC Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Allergy Therapeutics PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Allergy Therapeutics PLC Frequently Asked Questions
What is Allergy Therapeutics PLC(FRA:HHU)'s stock price today?
The current price of FRA:HHU is €0.05. The 52 week high of FRA:HHU is €0.23 and 52 week low is €0.05.
When is next earnings date of Allergy Therapeutics PLC(FRA:HHU)?
The next earnings date of Allergy Therapeutics PLC(FRA:HHU) is 2023-09-29 Est..
Does Allergy Therapeutics PLC(FRA:HHU) pay dividends? If so, how much?
Allergy Therapeutics PLC(FRA:HHU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers